- Home
- WBS vs PCVX Comparison
WBS vs PCVX Comparison
Compare WBS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WBS | PCVX |
|---|---|---|
| Founded | 1935 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 6.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WBS | PCVX |
|---|---|---|
| Price | $65.33 | $44.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | $72.33 | ★ $105.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.3M |
| Earning Date | 01-23-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | ★ 21.39 | N/A |
| EPS | ★ 5.36 | N/A |
| Revenue | ★ $2,581,185,000.00 | N/A |
| Revenue This Year | $8.46 | N/A |
| Revenue Next Year | $5.53 | N/A |
| P/E Ratio | $12.04 | ★ N/A |
| Revenue Growth | ★ 8.65 | N/A |
| 52 Week Low | $39.43 | $27.66 |
| 52 Week High | $65.98 | $93.77 |
Technical Indicators
Market Signals| Indicator | WBS | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 63.50 | 45.88 |
| Support Level | $64.28 | $43.95 |
| Resistance Level | $65.98 | $47.55 |
| Average True Range (ATR) | 1.23 | 1.87 |
| MACD | -0.10 | -0.16 |
| Stochastic Oscillator | 86.82 | 36.57 |
Price Performance
Historical ComparisonAbout WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.